For digital health startups, the first two months of this year were a welcome departure from 2022, when high inflation and other economic challenges caused investors to press on the brakes and proceed with caution....more
There are more investors in digital health today than there have ever been, but the questions they are posing to company founders before writing a check are tougher than they were just a year ago....more
Digital health has been a powerhouse investment sector since it emerged more than a decade ago. Year-after-year, startups consistently demonstrate their innovations bring real-world benefits and our healthcare system...more
As the financial markets continue to struggle, digital health companies are conserving resources, slowing hiring and minding their burn rate given the uncertainty around the current economic slowdown and whether the economy...more
7/13/2022
/ Apple ,
Artificial Intelligence ,
Big Tech ,
Digital Health ,
Google ,
Healthcare ,
Innovative Technology ,
Investment Opportunities ,
Life Sciences ,
Microsoft ,
Pharmaceutical Industry ,
Popular ,
Startups
Investors are understandably cautious this year as the Federal Reserve tightens monetary policies and financial markets erased the gains from the last 12 months. Public company investors in sectors with enticing upside—like...more
The digital health sector emerged as a juggernaut during the COVID-19 pandemic, with almost $15 billion invested in privately-held digital health companies in 2020 and nearly $30 billion invested last year, according to our...more
2/14/2022
/ Capital Markets ,
Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
In the technology sector, entrepreneurs are often told to “move fast and break things.” But breaking things is something that won’t work in healthcare, so, as an alternative, innovators may consider “moving fast and keeping...more
At the end of Q1 2021, our friends at Rock Health noted the record-breaking $6.7 billion raised by digital health startups and declared the sector “all grown up.” The additional $8 billion raised in the second quarter of this...more
In prior years, it was almost a foregone conclusion that promising digital health startups would be acquired by other companies before having the opportunity to debut on the public markets. However, that changed in 2019,...more
2/17/2021
/ Digital Health ,
Financial Markets ,
Initial Public Offering (IPO) ,
Innovative Technology ,
Investment Opportunities ,
Life Sciences ,
Pharmaceutical Industry ,
Special Purpose Acquisition Companies (SPACs) ,
Startups ,
Stock Prices ,
Venture Capital
When investors survey the digital health sector today, they see nearly every number trending upward.
There is more deal volume than VCs have seen in past years, with the third quarter of 2020 outpacing anything they’ve...more
Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo....more
Venture investors are pleased to see digital health companies continue to transform the healthcare system despite unprecedented challenges brought by the COVID-19 pandemic....more
Despite the changes and uncertainty rippling across the entire venture-backed startup ecosystem, the digital health sector saw its best first quarter since analysts began tracking its performance more than a decade ago,...more
The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year....more
1/24/2020
/ Biosimilars ,
Biotechnology ,
Bristol-Myers Squibb ,
China ,
Digital Health ,
Genetic Materials ,
Genetic Testing ,
Investment ,
Investment Opportunities ,
JPMorgan Chase ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
UK Brexit ,
US Trade Policies ,
Venture Capital
Fenwick’s eighth annual Digital Health Investor Summit took place against the backdrop of strong and increasingly diverse investment markets, a focus on clinical validation of digital health tools, and a healthcare system...more
11/21/2019
/ Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
The business of animal health has traditionally been dominated by the animal health divisions of big pharma companies. But with Pfizer’s 2013 spin-off of its animal health business, now known as Zoetis, the sector has been...more
5/17/2019
/ Animal Drugs ,
Animal Health ,
Biotechnology ,
Divestiture ,
Industry Consolidation ,
Investment Opportunities ,
Life Sciences ,
Pets ,
Pharmaceutical Industry ,
Popular ,
Startups
With 58 U.S. biopharma IPOs in 2018, the biotech industry entered the new year with confidence. By all appearances, the longest and largest biotech IPO window in history was not going to close anytime soon. ...more
No matter who is doing the counting, 2018 was an off-the-charts year for venture investment in digital health. Here’s a sampling of the tallies...more
The Seventh Annual Fenwick & West Digital Health Investor Summit profiled a sector that continues to attract record levels in investment, further matures and consolidates, and that is leveraging the newest technologies in...more
Just over a year ago, we reported about the rise of the mega-round in digital health investments. At that time, we tallied nine investment rounds valued at more than $100 million in the first half of 2017. ...more